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Objective: To assess the antioxidant and anti-inﬂammatory activities as well as to
determine the ﬂavonoids and phenolic acids content of active fractions.
Methods: Two medicinal plant samples were extracted successively in Soxhlet apparatus
with n-hexane, dichloromethane, acetonitrile, ethyl acetate, methanol and n-butanol. Five
methods were used to evaluate the antioxidant activity. Anti-inﬂammatory activity was
done through the inhibition of the cyclooxygenase enzymes (COX-1 and COX-2).
Polyphenolic compounds were analyzed by using a spectrophotometrical and high per-
formance liquid chromatography-mass spectrometry (HPLC-MS) methods.
Results: The data showed that the stem leaves extracts of Commiphora africana and
Loeseneriella africana possessed signiﬁcant in vitro antioxidant and anti-inﬂammatory
activities. Polar extracts had radical scavenging effects and they reduced iron (III). The
prostaglandin production was signiﬁcantly stopped by acetonitrile and methanol extracts.
These biological activities were supported by some bioactive compounds quantiﬁed by
using the HPLC-MS. p-Coumaric acid, ferulic acid, isoquercitrin, quercitrin, quercetin,
rutin, kaempferol and apigenin were the most metabolites quantiﬁed.
Conclusions: The present study may explain the effectiveness of plants in traditional
medicine of Burkina Faso, singularly Commiphora africana and Loeseneriella africana.
The next investigation was to sub-fractionate the methanol fraction in order to isolate new
antioxidant and/or anti-inﬂammatory compounds.1. Introduction
Previous ethnobotanical investigations have demonstrated
the importance of traditional medicine in maintaining peoplehealth in Burkina Faso [1,2]. A large number of medicinal plants
were well known and traditionally used for the treatment of
malaria, wound, cancer, HIV, diarrhea, inﬂammation and
cardiovascular diseases [1–4]. These data indicated the
importance of ethnopharmacological knowledge in Burkina
Faso. Moreover, there are few pharmacological and
phytochemical studies for valorizing traditional medicine and
phytotherapy according to Zizka et al. [1].
Commiphora africana (C. africana) and Loeseneriella afri-
cana (L. africana) were well-known medicinal plants used in the
treatment of cancer, malaria, wound and inﬂammatory disease in
Burkina Faso and other countries [2,5]. Previous biological
investigations from Nigeria, Kenya and South Africa showedarticle under the CC BY-NC-ND license (http://
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antiplasmodial and antitumoral activities of C. africana
extracts [6–8]. These results were supported by in vivo studies
such as antilipidaemic, hypoglycemic and anti-inﬂammatory
properties [9–11]. As for L. africana, it was demonstrated that
this plant possessed anti-malarial activities [5].
The phytochemical investigations focused on volatile compound
from gum, resin and oil such as monoterpenes [12]. The preliminary
phytochemical screening of C. africana extract revealed the
presence of ﬂavonoids, tannin, anthraquinone, triterpenoides,
saponins and alkaloids [11]. A dihydroﬂavonol glucoside from
C. africana that mediates DNA strand scission was identiﬁed [13].
In contrast, the phytochemical studies of L. africana were not yet
done. This work ﬁlls a gap in pharmacology and phytochemical
knowledge in Burkina Faso. Thereby, the interactions between the
plant extracts and the antioxidant and the anti-inﬂammatory pa-
rameters were evaluated in vitro. This research was achieved by
phytochemical investigations.
2. Materials and methods
2.1. Plants
Stemwith leaves of L. africana (Celastraceae) andC. africana
(Burseraceae) were collected from central region of Burkina Faso
in September 2011. After identiﬁcation and authentication,
voucher specimens were deposited at the Herbarium of the Uni-
versity of Ouagadougou under the voucher specimen number
mcompaore_5 and mcompaore_6 respectively.
2.2. Chemical material
Folin–Ciocalteu reagent, sodium phosphate mono- and di-
basics, sodium tetraborate, potassium persulfate, aluminum tri-
chloride, trolox, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,20-
azinobis(3-ethylbenzoline-6-sulphonate) (ABTS), gallic acid and
trichloro acetic acid (TCA) were purchased from Sigma–Aldrich
(Germany). Sodium carbonate, potassium hexacyanoferrate,Table 1
Antioxidant activities and total polyphenolic contents.
Plant Extract Yield*
(mg/g)
Antioxidant a
ABTS
(mMET/g)
DPPH
(mgQE/g)
FRA
(mgAA
L. africana HF 25.56 6.62 ± 1.30f 7.49 ± 0.09 21.59 ±
DCMF 7.54 17.08 ± 1.34e 56.10 ± 2.93 88.17 ±
ACNF 9.76 21.50 ± 0.73d 63.33 ± 0.78ab 118.67 ±
EAF 3.36 34.57 ± 2.27b 63.51 ± 0.11ab 271.52 ±
MeOHF 185.24 26.08 ± 1.16c 65.01 ± 0.33a 186.59 ±
BuOHF 2.20 21.59 ± 2.39d 61.25 ± 0.13b 133.95 ±
C. africana HF 27.12 5.06 ± 0.48f Non active 15.03 ±
DCMF 5.48 13.98 ± 0.72e 32.99 ± 0.86 78.22 ±
ACNF 15.40 40.75 ± 0.43a 64.45 ± 0.05a 435.77 ±
EAF 15.40 37.60 ± 1.00ab 64.16 ± 0.32a 365.42 ±
MeOHF 101.28 22.13 ± 1.19d 61.13 ± 0.30b 157.40 ±
BuOHF 1.02 29.47 ± 0.42c 62.50 ± 0.05ab 264.25 ±
n = 2 × 3 except asterisk data that were obtained by one procedure extraction
with same letters. TPC: Total phenolic content; TFC: Total ﬂavonoid content
inhibition percentage; I% DRB: Deoxyribose degradation inhibition percent
Acetonitrile fraction; EAF: Ethyl acetate fraction; MeOHF: Methanol fractio
gram; mgEAA/g: mg ascorbic acid equivalents/gram; mgGAE/g: mg gallicascorbic acid and ferric chloride were from Prolabo (France).
Caftaric, gentisic, ferulic, sinapic, caffeic, chlorogenic and p-
coumaric acids, and patuletin, luteolin, hyperoside, isoquercitrin,
rutin, myricetin, ﬁsetin, quercitrin, quercetin, kaempferol and
apigenin were purchased from Roth (Germany) and Dalton
(USA). All solvents used were high-performance liquid chro-
matography (HPLC) or analytic grades.2.3. Apparatus and chromatographic conditions
An Agilent 1100 HPLC Series system (Agilent, USA)
coupled with an Agilent 1100 mass spectrometer (LC/MSD Ion
Trap VL) was used for chromatographic analysis. The full
experimental description was showed in Compaore´ et al. pre-
vious publication [14].2.4. Extraction
Twenty-ﬁve grams of powder from each plant was succes-
sively fractioned with n-hexane, dichloromethane, acetonitrile,
ethyl acetate, methanol and n-butanol in Soxhlet apparatus ac-
cording to method of Dastmalchi et al. with slight modiﬁcations
[15]. The organic solvents were removed in rotary evaporator
system under reduced pressure. The mass of extractable
compounds were indicated in Table 1.2.5. Biological investigations
2.5.1. Inhibition of radical DPPH assay
Extracts capacity to inhibit DPPH radical was evaluated as
described by Lamien-Meda et al. with some modiﬁcations [16].
In a 96 micro-well plate, 200 mL of DPPH (20 mg/L) and
100 mL of sample were incubated in dark for 10 min, following a
reading at 517 nm (BioTek Instruments, USA). Quercetin was
used to generate a standard curve (y = −27.94x + 8.15; r2 > 0.99;
P < 0.000 1). The data expressed in mg equivalent of quercetin
per gram was the average of 2 independent triplet tests.ctivities Phytochemical analysis
P
E/g)
I% LPO I% DRB TPC
(mgGAE/g)
TFC
(mgQE/g)
4.65e Non active 65.33 ± 0.44b 90.42 ± 6.53 13.70 ± 0.65
3.81d Non active 66.53 ± 0.88b 206.54 ± 9.47 17.58 ± 0.57
3.27c Non active 70.32 ± 0.84a 246.45 ± 6.66c 11.26 ± 0.36
7.33a 41.79 ± 2.24 69.65 ± 0.79a 439.75 ± 3.33a 8.47 ± 0.27
7.97 70.07 ± 0.36 66.72 ± 0.55b 368.20 ± 11.53b 3.84 ± 0.08
2.02bc 28.71 ± 0.34 70.32 ± 0.52ac 371.15 ± 4.61b 30.21 ± 0.49
2.14e Non active Non active 5.86 ± 0.64 Non detected
3.55d 64.57 ± 0.81 60.78 ± 0.48 150.51 ± 2.40 1.48 ± 0.06
20.57 58.51 ± 1.68 83.79 ± 0.28 819.39 ± 10.56 0.21 ± 0.03
8.99 65.25 ± 3.59 80.24 ± 0.33 719.45 ± 2.78 6.18 ± 0.13
4.67b 78.57 ± 3.04 73.44 ± 0.17c 260.73 ± 4.50c Non tested
9.35a 64.02 ± 1.19 77.06 ± 0.19a 424.90 ± 12.55a Non tested
. Data in each column were statistically different (P < 0.05) except data
; FRAP: Ferric reducing antioxidant power; I% LPO: Lipid peroxidation
age; HF: n-Hexane fraction; DCMF: Dichloromethane fraction; ACNF:
n; BuOHF: n-Butanol fraction; mMET/g: Millimole equivalent of trolox/
acid equivalent/gram; mgQE/g: mg quercetin equivalent/gram.
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The method described by Compaore´ et al. with some modi-
ﬁcations was used to evaluate the sample ABTS+ scavenging
ability [14]. To 200 mL of diluted ABTS+ solution, 50 mL of
extract was added for 5 min dark incubation. The absorbance
was read at 734 nm with microplate reader (BioTek
Instruments, USA). Trolox was used for generating standard
curve (y = −72.38x + 54.57; r2 > 0.99; P < 0.001) and the
result were expressed in mMET/g.
2.5.3. Reduction of iron III assay
The reducing power of extracts was determined according to
Compaore´ et al. method with some modiﬁcations [14]. In a tube,
0.5 mL of extract was mixed with 1.25 mL of phosphate buffer
(0.2 mol/L, pH 6.6) and 1.25 mL of 1% aqueous potassium
hexacyanoferrate. This mixture was incubated for 30 min
followed by an addition of TCA and centrifugated at 3000 r/
min for 10 min. In 96 micro-wells, the upper layer solution
(125 mL) was mixed with 125 mL of H2O and 25 mL of FeCl3
fresh solution. Ascorbic acid was used to produce the calibration
curve by reading the absorbencies at 700 nm (y = 105.9x;
r2 > 0.99; P < 0.0001). The iron (III) reducing activity of each
sample was obtained from 2 independent triplet determinations
and expressed in mgAAE/g of extract.
2.5.4. Lipid peroxidation inhibitory assay
The described method from Jaishree et al. in previous pub-
lication was used to evaluate the lipid peroxidation inhibition of
samples [17]. The production of chromogen A from lecithin
degradation was induced by FeCl3, ascorbic acid, TCA and 2-
thiobarbituric acid. The extract inhibitory powers (100 mg/mL)
were obtained by reading the absorbance at 532 nm. The inhi-
bition percentage was calculated by using a proper blank and
negative control. All tests were achieved for 2 triplet indepen-
dent assays.
2.5.5. Desoxyribose degradation inhibitory assay
The inhibition of desoxyribose degradation was assessed by
using the experimental procedure developed by Perje´si and
Rozmer [18]. In the presence of Fe2+-ethylene diamine tetraacetic
acid and H2O2 (10 mmol/L), the desoxyribose was degraded to
methane dicarboxylic aldehyde according to a Fenton reaction.
A combination of methane dicarboxylic aldehyde and 2-
thiobarbituric acid produced a color indicator reaction at
532 nm. The extract was used at 100 mg/mL of ﬁnal concen-
tration. All experiments were accomplished in triplicate for 2
independent tests. Hydroxyl radical scavenging effect was
expressed as the percentage of inhibition of 2-deoxyribose
oxidation.
2.5.6. Cyclooxygenase (COX) inhibition assay
Inhibition assay of COX-1 and COX-2 activities was per-
formed by using a commercial available colorimetric COX
(ovine) inhibitor screening assay kit (Cayman Chemical Com-
pany, USA). All the inhibitors added to the reaction system were
dissolved in appropriate solvent and prepared just before using.
In this assay, the COX activity was measured by using
N,N,N,0N0-tetramethyl-p-phenylenediamine (TMPD) as a co-
substrate with arachidonic acid. TMPD oxidation was moni-
tored spectrophotometrically with a 96-well plate reader at
590 nm (BioTek instruments, USA). Different extracts wereused at 100 mg/mL ﬁnal concentration in total volume of
220 mL.
2.6. Phytochemical investigations
2.6.1. TPC determination
TPC was evaluated by using Folin–Ciocalteu colorimetric
assay described by Compaore´ et al. with minor modiﬁcations
[14]. Twenty-ﬁve microliters of sample was added to 125 mL of
Folin–Ciocalteu reagent (0.2 mol/L) and incubated during 5 min
following by adding 100 mL of sodium carbonate (75 g/L). After
1 h of dark incubation, the absorbance was recorded at 760 nm
with microplate reader. Gallic acid was used to produce the
standard curve (y = 201x – 21.22, r2 > 0.99, P < 0.0001) and the
results were done in mgGAE/g of extract.
2.6.2. TFC determination
TFC was determined according to previous method
described by Compaore´ et al. with some modiﬁcations [14].
One hundred microliters of sample and 100 mL of AlCl3
(2%) were mixed in 96 micro-well plate and incubated for
10 min. The absorbance was measured at 415 nm with
microplate reader. The standard curve was generated with
variable concentration of quercetin at 415 nm (y = 39.8x – 3.5;
r2 = 0.99, P < 0.0001) and the results were done as mgQE/g
of sample.
2.6.3. Identiﬁcation and quantitative determinations of
polyphenols
To assess the quantities of polyphenolic compounds in the
bioactive fractions, the previous experimental processing was
used according to Compaore´ et al. [14]. Seven phenolic acids and
11 ﬂavonoid compounds were used as internal standard HPLC
analysis. The mass spectrometry was used for compound
identiﬁcation and the UV trace was used for the identiﬁed
compound quantiﬁcation.
2.7. Data analysis
All data were analyzed by using Excel for calculating means
and standard deviation. One-way ANOVA of GraphPad soft-
ware was used for measuring the statistical difference and
obtaining the graph and correlation.
3. Results
3.1. Antioxidant activities
The antioxidative activity of the plant extracts was evaluated
by 5 methods and the results were shown in Table 1. ABTS
radical scavenging activities were decreasing from
(40.75 ± 0.43) to (5.06 ± 0.48) mMET/g. In contrast, all frac-
tions were presented similar DPPH radical scavenging effect
(around 60 mgQE/g) except HF and DCMF. Interestingly, all
fractions were showing powerful iron (III) reduction ability
which increased from (15.03 ± 2.14) to (435.77 ± 20.57)
mgAAE/g. Concerning the lipid peroxidation inhibition effect,
all the fractions (100 mg/mL ﬁnal concentration) of C. africana
were active except HF. Meanwhile, only BuOHF, MeOHF and
EAF from L. africana were able to inhibit lipid peroxidation.
MeOHFs from C. africana and L. africana were presenting the
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(70.07 ± 0.36)% respectively. All active fractions presented an
IC50 inferior to 100 mg/mL (ﬁnal concentration) in desoxyribose
degradation inhibition, with ACNF from C. africana inhibiting
(83.79 ± 0.28)%. According to the total antioxidant activity, the
best fractions were EAF, MeOHF and BuOHF from L. africana
and ACNF, EAF and BuOHF from C. africana. In general,
C. africana fractions showed better antioxidant activity than
L. africana fractions.
3.2. Anti-inﬂammatory effect
The inhibition percentage of prostaglandins biosynthesis was
presented in Figure 1. According to our data, COX-1 inhibition
was decreased from (67.36 ± 0.29)% to (10.16 ± 2.71)% and
COX-2 inhibition from (64.24 ± 1.16)% to (12.74 ± 1.90)%. In
considering the type of extract, it was shown that COX in-
hibitors were in polar extract. Certainly, the different extracts
contained some bioactive metabolites.
3.3. Phenolic and ﬂavonoid contents
The yield data in Table 1 showed the existence of extractive
compounds with extensive polarity. Particularly, plants con-
tained some variable phenolic and ﬂavonoid metabolites. The
TPC was ranging from (819.39 ± 10.56) to (5.86 ± 0.64)
mgGAE/g and the highest ﬂavonoid content was
(30.21 ± 0.49) mgQE/g. Remarkably, all the extracts from
C. africana were very poor in ﬂavonoid content contrary to the
fractions from L. africana. For example, ﬂavonoid content
represented around 8% of phenolics from BuOHF from
L. africana.C. africana L. africana
C. africana L. africana
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Figure 1. Inhibition percentage of COX-1 and COX-2.
Data with same letters were not statistically signiﬁcant. n = 2 × 3.3.4. Phenolic compositions analysis
Polar fractions of plants were analyzed by high performance
liquid chromatography-mass spectrometry (HPLC-MS) but only
data from EAF, ACNF (L. africana) and BuOHF (C. africana)
analysis were shown in Tables 2 and 3. The two fractions from
L. africana presented the similar chromatographic proﬁle with
isoquercitrin, rutin, quercetin, quercitrin and p-coumaric acid
that were quantiﬁed. EAF from C. africana was distinguished to
EAF from L. africana by the presence of kaempferol and api-
genin. The proﬁle of BuOHF from C. africana was characterized
by the presence of ferulic acid, p-coumaric acid [931.36 mg
equivalent/gram (mgE/g)], rutin, isoquercitrin, quercetin and
quercitrin (126.83 mgE/g). Gentisic and ferulic acids were
detected in ACNF from L. africana, gentisic and chlorogenic
acids in EAF and gentisic and caffeic acids in BuOHF from
C. africana. In contrast, caftaric and sinapic acids, hyperoside,
myricetin, ﬁsetin, patuletin and luteolin were not identiﬁed in the
fractions of plants. According to the chromatogram proﬁles (data
not shown), ﬁve unknown major compounds were notiﬁed at
8.5, 9.4, 12.2, 22.3 and 28 min (retention time) in EAF and 3
compounds at 22–25 min in BuOHF from C. africana. As in
C. africana fractions, L. africana fraction showed ﬁve major
compounds at 18.7, 21.1, 21.9, 23.4 and 24.9 min in EAF and
seven compounds from 21.5 to 33 min in ACNF. The unknown
compounds with the retention superior to 20 min could be ﬂa-
vonoids according to their high retention time and UV absor-
bance. While the HPLC analysis data of MeOH, BuOHF from
L. africana and ACNF from C. africana were not presented in
the present study. According to their biological and phyto-
chemical proﬁling, they will be used in the anti-COX compound
isolation. The metabolites contributed to antioxidant and anti-
inﬂammatory effects signiﬁcantly (Table 4). There were a sig-
niﬁcant correlation between phenolic contents and antioxidant
activity and a good speciﬁc contribution of ﬂavonoids that wasTable 2
Identiﬁed and quantiﬁed compounds (mgE/g) in L. africana by HPLC-
MS analysis.
Compounds EAF ACNF Total quantity
p-Coumaric acid 22.83 34.10 56.93
Isoquercitrin 19.80 15.95 35.75
Rutin 12.55 08.85 21.40
Quercitrin 20.90 34.95 55.85
Quercetin 04.35 04.93 09.28
Data were obtained by one procedure analysis.
Table 3
Identiﬁed and quantiﬁed compounds (mgE/g) in C. africana by HPLC-
MS analysis.
Compounds EAF BuOHF Total quantity
p-Coumaric acid – 951.45 951.45
Ferulic acid – 29.10 29.10
Rutin 51.50 88.25 139.75
Isoquercitrin 15.40 70.40 85.80
Quercitrin 22.52 126.83 149.35
Quercetin 26.25 15.35 41.60
Kaempferol 14.30 – 14.30
Apigenin 13.38 – 13.38
Data were obtained by one procedure analysis.
Table 4
Positive correlation matrix.
TPC ABTS FRAP COX-
1
COX-
2
DPPH I%
LPO
I%
DRB
TPC 1
ABTS 0.95 1
FRAP 0.98 0.96 1
COX-1 0.63 0.75 0.64 1
COX-2 0.59 0.63 0.58 0.87 1
DPPH 0.70 0.82 0.68 0.75 0.50 1
I% LPO 0.55 0.60 0.60 0.32* 0.27* 0.51 1
I% DRB 0.66 0.68 0.61 0.31* 0.06* 0.77 0.47 1
Asterisk data mean an unsigniﬁcant correlation.
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contributed to COX inhibition signiﬁcantly (r = 0.60, P < 0.05).
4. Discussion
According to World Health Organization statistical studies,
people in Burkina Faso have a very low economic level and the
population used the plants for health care appropriately [19].
These facts lead scientists from Burkina Faso to focus their
interest in improving traditional medicine. The purpose of this
investigation was to assess the antioxidative and anti-
inﬂammatory effects as well as to determine the phenolics
composition of active extracts of medicinal plants. Our ﬁnding
has demonstrated the interesting antioxidant activity of EAF,
MeOHF and BuOHF from the 2 plants as well as the enzymes
inhibitory effect of ACNF, EAF and MeOHF. According to
Fawole et al. [20] and Vogl et al. [21], MeOHF, EAF, ACNF
from L. africana and ACNF from C. africana which presented
a hight COX-1 inhibition at 100 mg/mL could contain some
potential inhibitors in a ﬁrst level, and MeOHF and EAF from
L. africana and ACNF from C. africana in a second level.
According to previous study, C. africana stem leaves extracts
showed the anti-DPPH and anti-ABTS+ effects and didn't
present any 5-lipoxygenase inhibitory effect, an inﬂammatory
enzyme [6].
These antioxidant and anti-inﬂammatory activities can be
explained by the presence of metabolites notably, including the
total phenolics and ﬂavonoids found in different extracts and the
identiﬁed compounds. The signiﬁcant correlation of phenolics to
the biological activity conformed with previous data that indi-
cated the important contribution of phenolics and ﬂavonoids
[14,16,22]. Thereby, the anti-DPPH and anti-ABTS+ activities of
quercitrin, isoquercitrin, rutin and p-coumaric acid have been
demonstrated [23–25]. Additionally, rutin, isoquercitrin,
quercetin, apigenin and kaempferol, ferulic acid and caffeic
acid were good lipid peroxidation and desoxyribose
degradation inhibitors [23,24,26,27]. In the same way, p-
coumaric acid, rutin, isoquercitrin, quercetin and kaempferol
have been shown to possess anti-COX activity [28–31].
Interestingly, the signiﬁcant correlation between antiradical
scavenging and COX inhibition in the ﬁrst way and between
the Fe3+ reduction and COX inhibition in the second way
suggested a mechanism of fractions inhibitory actions
(Table 4). For instance, plant extract by reducing iron in COX
heme could jam enzyme activity. Mechanistically, these data
could be explained the in vivo anti-inﬂammatory effect and the
DNA scission regulation of extracts from C. africana and itsdihydroﬂavonol [11,13,32]. The antioxidant and anti-inﬂammatory
properties of these plants could justify its importance in the ﬁght
against oxidative stress diseases and its corollaries.
The presented study could explain the effectiveness of plants
in traditional medicine in Burkina Faso, singularly C. africana
and L. africana. In biological activities, the plant extracts pre-
sented some potential antioxidant and anti-inﬂammatory effects.
The biological effects were explained by the content of bioactive
compounds revealed by HPLC-MS analysis. Thereby, iso-
quercitrin, rutin, quercitrin, quercetin and p-coumaric acid,
gentisic and ferulic acids were found to be the bioactive com-
pounds in L. africana and C. africana extracts. Additionally,
caffeic and chlorogenic acids, kaempferol and apigenin were
detected in C. africana extract. The near future is to isolate new
bioactive compounds form these plants.
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